WASHINGTON, D.C. — Ohio’s health-care industry hopes Congress will help pick up part of the tab for emergency medical helicopters, technology upgrades, new drug development and commercial research.
Altogether, there are easily $50 million in health-related federal earmarks from Ohio legislators that could fund projects from the James Cancer Hospital at Ohio State University to a company researching cell therapy for battlefield wounds. Votes in Senate and House committees are expected this month to determine whether the institutions would get some, all, or any of their requests.
The James has one of the larger requests: a $5 million earmark that would continue to develop gene therapy drugs in the center’s neuroscience clinical gene therapy center. The hospital received funding for the project last year. Now, it wants to use $5 million to work with Nationwide Children’s Hospital to produce gene therapy drugs, said Jen Carlson, governmental relations director at the Columbus cancer hospital.
MetroHealth Medical Center in Cleveland is lobbying for $2 million to cover part of the $28 million to $30 million it cost to buy three new helicopters. The money would be used for medical equipment for Metro Life Flight, said Eileen Korey, MetroHealth’s vice president for communications.
Additional earmarks under consideration include:
Ohio’s Steris Corp. is getting a boost from outside the state. A Missouri legislator has requested the company get $5.3 million to work on a decontamination system there.
Comments
Post a comment
[...] earmarks go towards funding research and operations at universities across the country, or support cancer research at medical centers, resulting in public goods that benefit the country as a whole. [...]
Comment by Earmarks: Friend or Foe? « Budget Insight — September 28, 2009 @ 10:19 am
Post a Comment